Search Results 181-190 of 7361 for infliximab

  1. Aflibercept-jbvf (intraocular route) - Mayo Clinic

    Aflibercept-jbvf injection is used to treat neovascular (wet) age-related macular degeneration (AMD). AMD is a disorder of the retina in the eye that causes ...

  2. Adalimumab-bwwd (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-bwwd injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...

  3. Postoperative Infections Clinical Trials

    ... infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side ...

  4. PR3-AAV Resilient Remission Or PRRR - Clinical Trials

    History of intolerance to rituximab or other chimeric monoclonal antibodies (e.g., infliximab). Recent vaccination: They have had a live vaccine fewer than ...

  5. Vedolizumab IV 300 Mg In The Treatment Of Fistulizing Crohn's Disease - Mayo Clinic

    France only: The participant, historically, failed (ie, had an inadequate response with, lost response to, or was intolerant to) infliximab for treatment of ...

  6. Filgrastim-sndz (intravenous route, subcutaneous route) - Mayo Clinic

    Filgrastim-sndz injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic (man-made) form of a ...

  7. Ustekinumab-srlf (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  8. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of ABT-494 For The Induction Of Symptomatic And Endoscopic Remission In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Immunomodulators Or Anti-TNF Therapy - Mayo Clinic

    ... infliximab, adalimumab, or certolizumab pegol). Exclusion Criteria: Subjects with ulcerative colitis (UC), collagenous colitis or indeterminate colitis ...

  9. Psoriasis - Diagnosis and treatment - Mayo Clinic

    It's less effective than adalimumab and infliximab. It might cause upset stomach, loss of appetite and fatigue. People taking methotrexate long-term need ...

  10. Adalimumab-atto (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Adalimumab-atto injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing ...